CL2008003185A1 - Procedimiento para la preparacion de medetomidina que considera el acoplamiento entre un siliimidazol y un derivado de alcohol bencilico. - Google Patents

Procedimiento para la preparacion de medetomidina que considera el acoplamiento entre un siliimidazol y un derivado de alcohol bencilico.

Info

Publication number
CL2008003185A1
CL2008003185A1 CL2008003185A CL2008003185A CL2008003185A1 CL 2008003185 A1 CL2008003185 A1 CL 2008003185A1 CL 2008003185 A CL2008003185 A CL 2008003185A CL 2008003185 A CL2008003185 A CL 2008003185A CL 2008003185 A1 CL2008003185 A1 CL 2008003185A1
Authority
CL
Chile
Prior art keywords
medetomidine
silyimidazole
considers
derivative
procedure
Prior art date
Application number
CL2008003185A
Other languages
English (en)
Inventor
Rasik Somaiya
Muhammad Raza
Jonathan Cranke
Kristian Bragg
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of CL2008003185A1 publication Critical patent/CL2008003185A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Procedimiento para preparar medetomidina que comprende hacer reaccionar alcohol 2,3-dimetil-metilbencilico con n-trimetilsililimidazol.
CL2008003185A 2007-10-24 2008-10-24 Procedimiento para la preparacion de medetomidina que considera el acoplamiento entre un siliimidazol y un derivado de alcohol bencilico. CL2008003185A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0720891A GB2453982B (en) 2007-10-24 2007-10-24 Chemical process for the preparation of Medetomidine

Publications (1)

Publication Number Publication Date
CL2008003185A1 true CL2008003185A1 (es) 2009-03-06

Family

ID=38829878

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003185A CL2008003185A1 (es) 2007-10-24 2008-10-24 Procedimiento para la preparacion de medetomidina que considera el acoplamiento entre un siliimidazol y un derivado de alcohol bencilico.

Country Status (6)

Country Link
AR (1) AR068952A1 (es)
CL (1) CL2008003185A1 (es)
GB (1) GB2453982B (es)
PE (1) PE20091088A1 (es)
UY (1) UY31415A1 (es)
WO (1) WO2009053709A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101921234B (zh) * 2009-06-12 2012-05-30 中国中化股份有限公司 一种制备美托咪啶的方法
CN102753532B (zh) * 2009-12-09 2015-05-13 I-技术有限公司 美托咪定的制备方法
CN103748077B (zh) 2011-07-22 2016-08-17 坎布雷卡尔斯库加公司 用于制备4-取代咪唑类的方法
WO2013011156A2 (en) 2012-05-08 2013-01-24 Lonza Ltd Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal
PL2847173T3 (pl) * 2012-05-08 2016-06-30 Lonza Ag Sposób wytwarzania medetomidyny
WO2012172119A2 (en) * 2012-05-08 2012-12-20 Lonza Ltd Method for the preparation of medetomidine
KR101560116B1 (ko) * 2012-06-28 2015-10-13 론자 아게 (론자 엘티디.) 클로로아세톤을 이용한 메데토미딘의 제조 방법
BR112014022268A8 (pt) 2012-06-28 2019-05-28 Lonza Ag método para preparação de 2-(2,3-dimetilfenil)-1-propanal com cloroacetona
CN106588777A (zh) * 2015-10-16 2017-04-26 江苏开元医药化工有限公司 一种盐酸右美托咪定的工业化制备方法
CN117295718A (zh) 2022-03-22 2023-12-26 维科-兹多洛夫希沃特尼赫有限责任公司 美托咪定及其衍生物的制备方法
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
WO2009053709A1 (en) 2009-04-30
GB0720891D0 (en) 2007-12-05
AR068952A1 (es) 2009-12-16
PE20091088A1 (es) 2009-07-20
UY31415A1 (es) 2009-05-29
GB2453982B (en) 2009-09-16
GB2453982A (en) 2009-04-29

Similar Documents

Publication Publication Date Title
CL2008003185A1 (es) Procedimiento para la preparacion de medetomidina que considera el acoplamiento entre un siliimidazol y un derivado de alcohol bencilico.
NO20171811A1 (no) Fremgangsmåte for fremstilling av (1R,2R)-3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol
SI1885684T1 (sl) Derivativi 4- 2-amino-1-hidroksietil)fenola kot agonisti beta-2 adrenergičnega receptorja
UA101346C2 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы как гербициды
IL197294A0 (en) Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ??2 adrenergic receptor
TW200736195A (en) Methods for preparing sulfonamide substituted alcohols and intermediates thereof
MX339007B (es) Microcápsulas para regímenes alimenticios vegetarianos.
DE502008001947D1 (de) Wasseremulgierbare polyisocyanate
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
HK1123351A1 (en) Quick coupling particularly for the stock of a portable weapon
TN2010000064A1 (en) Novel herbicides
MX2010001364A (es) Derivados de ciclopentandiona puenteados triciclicos como herbicidas.
UA104438C2 (uk) Спосіб одержання дабігатрану і його проміжних сполук
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
RS53586B1 (en) DERIVATION OF DECISION
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
WO2009146099A3 (en) Contrast agents, methods for preparing contrast agents, and methods of imaging
TN2010000094A1 (en) Novel herbicides
MX2009006479A (es) Derivados de hemicelulosa y estructuras que los emplean.
AR067605A1 (es) Recubrimientos electrodepositables cationicos que comprenden colofonia
GT200600010A (es) Procedimientos para la preparacion de alcoholes aminoetoxibencilicos
PL1865766T3 (pl) Gniazda dla niosek
WO2012016095A8 (en) Process for the preparation of the compound osi - 906
CL2008001913A1 (es) Procedimiento de prepararaciacin 2-(3-{6-[2-(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico; y uno de los compuestos intermediarios usado el procedimiento descrito.
ITTO20080025A1 (it) Attrezzatura per l'esecuzione di fori secanti.